Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Brian D Burt"'
Autor:
Kenji Murata, Munehide Nakatsugawa, Muhammed A Rahman, Linh T Nguyen, Douglas G Millar, David T Mulder, Kenji Sugata, Hiroshi Saijo, Yukiko Matsunaga, Yuki Kagoya, Tingxi Guo, Mark Anczurowski, Chung-Hsi Wang, Brian D Burt, Dalam Ly, Kayoko Saso, Alexandra Easson, David P Goldstein, Michael Reedijk, Danny Ghazarian, Trevor J Pugh, Marcus O Butler, Tak W Mak, Pamela S Ohashi, Naoto Hirano
Publikováno v:
eLife, Vol 9 (2020)
HLA-restricted T cell responses can induce antitumor effects in cancer patients. Previous human T cell research has largely focused on the few HLA alleles prevalent in a subset of ethnic groups. Here, using a panel of newly developed peptide-exchange
Externí odkaz:
https://doaj.org/article/d455cc6e68c4440b81ba240acbcb367a
Autor:
Kenji Murata, Dalam Ly, Hiroshi Saijo, Yukiko Matsunaga, Kenji Sugata, Fumie Ihara, Daisuke Oryoji, Yota Ohashi, Kayoko Saso, Chung-Hsi Wang, Evey Y.F. Zheng, Brian D. Burt, Marcus O. Butler, Naoto Hirano
Publikováno v:
The Journal of Immunology. 209:1481-1491
The immunogenicity of a T cell Ag is correlated with the ability of its antigenic epitope to bind HLA and be stably presented to T cells. This presents a challenge for the development of effective cancer immunotherapies, as many self-derived tumor-as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13a8258c3ce63974dc70958cc51deda9
https://doi.org/10.4049/jimmunol.2200305
https://doi.org/10.4049/jimmunol.2200305
Publikováno v:
Cellular Signalling. 106:110634
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a919310e370279133961b3dab36c581b
https://doi.org/10.1016/j.cellsig.2023.110634
https://doi.org/10.1016/j.cellsig.2023.110634
Publikováno v:
Current opinion in immunology. 69
Immunotherapy has established itself as a stalwart arm in patient care and with precision medicine forms the new paradigm in cancer treatment. T cells are an important group of immune cells capable of potent cancer immune surveillance and immunity. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::364ba4bc2444a7eeb6007c7c7f1a1484
https://pubmed.ncbi.nlm.nih.gov/33307272
https://pubmed.ncbi.nlm.nih.gov/33307272
Autor:
Yuki Kagoya, Danny A Ghazarian, Douglas G. Millar, Linh T. Nguyen, Michael Reedijk, Muhammed A. Rahman, Munehide Nakatsugawa, Tak W. Mak, Mark Anczurowski, David T. Mulder, Yukiko Matsunaga, Alexandra M. Easson, Dalam Ly, Kenji Murata, Chung-Hsi Wang, Marcus O. Butler, Kenji Sugata, David P. Goldstein, Trevor J. Pugh, Kayoko Saso, Naoto Hirano, Tingxi Guo, Hiroshi Saijo, Pamela S. Ohashi, Brian D Burt
Publikováno v:
eLife, Vol 9 (2020)
eLife
eLife
HLA-restricted T cell responses can induce antitumor effects in cancer patients. Previous human T cell research has largely focused on the few HLA alleles prevalent in a subset of ethnic groups. Here, using a panel of newly developed peptide-exchange
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::815b991497f609d638d4d7519ea7d0f3
https://elifesciences.org/articles/53244
https://elifesciences.org/articles/53244
Autor:
David T. Mulder, Michael Reedijk, Linh T. Nguyen, Naoto Hirano, Dalam Ly, Alexandra M. Easson, David P. Goldstein, Kayoko Saso, Tingxi Guo, Kenji Sugata, Pamela S. Ohashi, Hiroshi Saijo, Muhammed A. Rahman, Brian D Burt, Mark Anczurowski, Danny Ghazarian, Yuki Kagoya, Douglas G. Millar, Munehide Nakatsugawa, Trevor J. Pugh, Tak W. Mak, Kenji Murata, Chung-Hsi Wang, Marcus O. Butler, Yukiko Matsunaga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bc31b0c5ea85b38126c09cd1bcd6f06
https://doi.org/10.7554/elife.53244.sa2
https://doi.org/10.7554/elife.53244.sa2
Autor:
Kenji, Sugata, Yukiko, Matsunaga, Yuki, Yamashita, Munehide, Nakatsugawa, Tingxi, Guo, Levon, Halabelian, Yota, Ohashi, Kayoko, Saso, Muhammed A, Rahman, Mark, Anczurowski, Chung-Hsi, Wang, Kenji, Murata, Hiroshi, Saijo, Yuki, Kagoya, Dalam, Ly, Brian D, Burt, Marcus O, Butler, Tak W, Mak, Naoto, Hirano
Publikováno v:
Nature biotechnology. 39(8)
Peptide-major histocompatibility complex (pMHC) multimers enable the detection of antigen-specific T cells in studies ranging from vaccine efficacy to cancer immunotherapy. However, this technology is unreliable when applied to pMHC class II for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::26cdb7403988a91438f20f439a21c299
https://pubmed.ncbi.nlm.nih.gov/33649568
https://pubmed.ncbi.nlm.nih.gov/33649568